✦ LIBER ✦

P458 Long-term efficacy and safety of adalumumab in patients with Crohn's disease naïve to prior anti-TNFa therapy compared to prior infliximab failures

✍ Scribed by Papamichael, K.; Archavlis, E.; Konstantopoulos, P.; Kyriakos, N.; Tsironikos, D.; Drougas, I.; Tzanetakou, X.; Internos, I.; Anastasiadis, S.; Karatzas, P.; Mantzaris, G.

Book ID: 123048156
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 51 KB
Volume: 7
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(13)60479-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy of adalimumab in Paed

Long-term efficacy of adalimumab in Paediatric Crohn's disease patients naïve to other anti-TNF therapies

✍ J. Martín-de-Carpi; N. Pociello; V. Varea 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 177 KB

Cost-Effectiveness of Third-Line Anti-TN

Cost-Effectiveness of Third-Line Anti-TNF Therapy Compared to Natalizumab in Patients With Moderate-to-Severe Crohn's Disease With Two Prior Anti-TNF Failures

✍ Ananthakrishnan, Ashwin N. ;Hur, Chin ;Korzenik, Joshua R. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

P052 LONG-TERM EFFICACY AND SAFETY OF AD

P052 LONG-TERM EFFICACY AND SAFETY OF ADALIMUMAB TREATMENT IN A SINGLE-CENTER COHORT OF CROHN' S DISEASE PATIENTS WHO FAILED TO INFLIXIMAB TREATMENT

✍ K. Karmiris; M. Noman; F. Schnitzler; H. Fidder; I.E. Koutroubakis; E.A. Kouroum 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 73 KB